Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl cysteine in PCI patients
NCT01878669Phase 3Active, not recruiting
- Sponsor
- Suleyman Demirel University
- Start
- Jan 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in coronary artery disease (CAD), sponsored by Suleyman Demirel University. Started Jan 2013; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01878669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878669.